Eurofins Scientific, the leading provider of bioanalytical services to the global Food, Dietary Supplement and Biotech industries, has established a client liaison office in Southern California to meet growing demand for high tech laboratory services and support.

Eurofins Scientific, the global leader in bioanalytical services for the Food, Feed, Dietary Supplement, Pet Food, Animal Health and Biotech industries, has established a liaison office in Los Angeles, CA to supplement the sales and consulting efforts of its five US laboratories.   This new satellite office will especially support the dietary supplement and natural products analytical services offered by the Petaluma, CA laboratory.  The demand for testing services within these sectors has been phenomenal over the past year and California has been a driver for this growth. 

Chuck Hecht has been named as the Account Executive for the West Coast and will manage the Los Angeles, CA location.  Chuck will also work closely with the GeneScan laboratory, the leading GMO testing and Identity Preservation certification provider, which recently joined the Eurofins Group.  Several years experience in the dietary supplement and natural product testing industry and in the Identity Preservation certification industry will enable Chuck to provide clients with analytical solutions based on real world experience.

The pending final rule for Good Manufacturing Practices within the Dietary Supplement industry has already begun to change quality control practices and encouraged buyers and producers alike to more intensively monitor their products and ingredients.  This development, along with the renewed vibrancy of the dietary supplement industry, is expected to expand the growth of new and higher quality products that will require testing on a more frequent basis.  Other recent market forces such as low-carbohydrate diet plans, Organic and Identity Preserved foods, and non-GMO ingredients continue to drive the development of new products requiring highly sophisticated testing capabilities such as those offered by Eurofins Scientific.

Eurofins Scientific is a life sciences company operating internationally to provide a comprehensive range of bioanalytical support services utilizing the latest developments in biotechnology. The Group specializes in delivering analytical testing services to clients in a wide range of industries including the pharmaceutical, food, feed, pet food, animal health and dietary supplement sectors. The Eurofins Group aims to be the world market leader in the field of applied life sciences and is pursuing a dynamic expansion strategy to improve both its technology portfolio and its geographic reach. Through R&D, licensing and acquisitions, the Group draws on the latest developments in the field to offer its clients unparalleled analytical solutions.  

With over 2,000 staff members in more than 40 laboratories across 12 countries and a portfolio of around 5,000 reliable analytical methods for proving the authenticity, origin, safety, identity, and purity of biological substances, Eurofins Scientific is already a leading global provider of bioanalytical services. The Group is committed to supporting its clients’ objectives of ensuring that their products maintain the best possible quality and safety levels in all markets in which they operate. Eurofins Scientific intends to continue to develop, acquire or license the most comprehensive range of state-of-the-art analytical technologies in order to support its clients’ increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.

As a company of the Eurofins Group, GeneScan Europe AG operates in the area of quality and identity control of food and animal feed. The focus of activities is on the detection of genetically modified organisms (GMO) in seeds, agricultural commodities, semi-finished and finished products. The company meets its customers’ global requirements by operating its own analytical laboratories in Europe, North and South America and by establishing a network of strategic partners and licensees. In addition to offering analytical services, it also offers the corresponding diagnostics kits to third party laboratories. The group’s portfolio also includes design, implementation and certification of customized control programs and identity preservation systems along the entire production chain.

The shares of Eurofins Scientific are listed on Euronext in Paris (ISIN FR0000038259) and on the Frankfurt (WKN 910251) Stock Exchange (Reuters EUFI.LN, Bloomberg ERSC FP, ESF, EUFI.DE). GeneScan-shares (WKN 586150) are listed on the Frankfurt Stock exchange (Reuters GEPG.DE).